Ensign Peak Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.89M | Sell |
34,415
-2,979
| -8% | -$856K | 0.02% | 475 |
|
|
2025
Q1 | $11.5M | Sell |
37,394
-263
| -0.7% | -$81.1K | 0.02% | 426 |
|
|
2024
Q4 | $13.3M | Buy |
37,657
+640
| +2% | +$226K | 0.02% | 398 |
|
|
2024
Q3 | $13.3M | Buy |
37,017
+3,340
| +10% | +$1.2M | 0.02% | 406 |
|
|
2024
Q2 | $10.7M | Buy |
33,677
+7,205
| +27% | +$2.3M | 0.02% | 432 |
|
|
2024
Q1 | $6.08M | Sell |
26,472
-6,018
| -19% | -$1.38M | 0.01% | 574 |
|
|
2023
Q4 | $7.14M | Sell |
32,490
-1,236
| -4% | -$272K | 0.01% | 533 |
|
|
2023
Q3 | $7.62M | Sell |
33,726
-2,084
| -6% | -$471K | 0.02% | 461 |
|
|
2023
Q2 | $7.91M | Buy |
35,810
+15,250
| +74% | +$3.37M | 0.02% | 480 |
|
|
2023
Q1 | $4.6M | Buy |
20,560
+4,518
| +28% | +$1.01M | 0.01% | 597 |
|
|
2022
Q4 | $4.46M | Sell |
16,042
-60,015
| -79% | -$16.7M | 0.01% | 588 |
|
|
2022
Q3 | $15.9M | Buy |
76,057
+11,615
| +18% | +$2.43M | 0.04% | 298 |
|
|
2022
Q2 | $15.2M | Sell |
64,442
-740
| -1% | -$174K | 0.04% | 307 |
|
|
2022
Q1 | $11.7M | Buy |
65,182
+6,675
| +11% | +$1.2M | 0.02% | 391 |
|
|
2021
Q4 | $12.6M | Sell |
58,507
-14,053
| -19% | -$3.04M | 0.02% | 412 |
|
|
2021
Q3 | $13.4M | Buy |
72,560
+25,235
| +53% | +$4.66M | 0.03% | 377 |
|
|
2021
Q2 | $8.49M | Sell |
47,325
-2,165
| -4% | -$388K | 0.02% | 476 |
|
|
2021
Q1 | $8.28M | Buy |
49,490
+1,309
| +3% | +$219K | 0.02% | 469 |
|
|
2020
Q4 | $7.31M | Sell |
48,181
-261,873
| -84% | -$39.7M | 0.02% | 491 |
|
|
2020
Q3 | $31.3M | Buy |
310,054
+168,249
| +119% | +$17M | 0.08% | 218 |
|
|
2020
Q2 | $17.2M | Buy |
141,805
+96,521
| +213% | +$11.7M | 0.05% | 323 |
|
|
2020
Q1 | $4.29M | Buy |
45,284
+7,595
| +20% | +$720K | 0.01% | 552 |
|
|
2019
Q4 | $3.32M | Buy |
+37,689
| New | +$3.32M | 0.01% | 799 |
|